image

Authoritative Independent Monthly Share Selections Using Technical & Fundamental Analysis

Latest issue now available

UDG Healthcare - Shares rise above £7 for first time

April 2017

Investing in shares may lose you all or some of your money. Past performance is no indication of future performance. Some of the shares recommended here may be small company shares, which can be relatively illiquid and hard to trade and this makes such shares more risky than other investments.

  • Epic Code:
  • UDG
  • Price:
  • 725p
A pleasing month for the shares, which breached £7 for the first time and are 177p ahead of out tip at 548p in Jan ’16. The surge followed a bullish update for the three months to 31st December, which noted a “good start to the year”, albeit moderated by currency headwinds (weak sterling versus Euro). Ashfield (outsourcing of sales & marketing for pharmaceuticals firms) traded particularly strongly, helped by acquisitions while Sharp (outsourced packaging such as blister packs for pharma) was modestly ahead of a strong comparable period, with its new Allentown facility in the US increasing activity levels nicely.Significantly, guidance for the current year ending September is for constant currency eps growth of 13-16%, albeit s ...

To access our archive of articles and to receive current issues you need to subscribe.

Subscribe now

Already a subscriber? Login

With small companies there is an above average degree of risk compared to buying blue chips. Please be aware that we have not assessed the suitability of any of these investments for you. The newsletter simply states a personal view and diarises the editor’s investment decisions. Please speak to your stockbroker or other qualified individual to ascertain whether any of these companies mentioned would form useful additions to your own portfolios. Past performance is no indication of future success.

All material on this website is protected by copyright. You may use Information retrieved from the www.scsw.co.uk website for your own personal non-commercial use which means that you may not sell or copy this information to any third party without prior written consent. ISSN 1358-183X